Ekso Bionics Holdings, Inc. (EKSO)
EBITDA Growth
-324.16%
TTM · Period ending:
EKSO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-324.16%period ending
Latest reported-324.16%period ending
EKSO TTM EBITDA YoY % (-38387.70% → -324.16%)
Year-over-year change
High-resolution chart · PNG
EKSO ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -324.1633% | |
| -47.1561% | |
| -2.0523% | |
| 1.4047% | |
| 9.1753% | |
| 26.2439% | |
| 28.3701% | |
| 33.9518% | |
| 29.7589% | |
| 9.1648% | |
| 6.0043% | |
| 2.1542% | |
| -27.4561% | |
| -36.3096% | |
| -54.4554% | |
| -36.2387% | |
| -99.4648% | |
| 38.9278% | |
| 39.6655% | |
| 25.9216% | |
| 63.9195% | |
| -126.1365% | |
| -36.2453% | |
| -12.407% | |
| 15.9837% | |
| 69.7162% | |
| 55.5529% | |
| 53.0759% | |
| 24.8289% | |
| -3.2381% | |
| -6.1753% | |
| -10.8117% | |
| -5.7893% | |
| 5.4882% | |
| -2.7269% | |
| -5.8956% | |
| -15.659% | |
| -16.3234% | |
| -22.5158% | |
| -13.0744% | |
| -12.5955% | |
| -21.7777% | |
| 80.2929% | |
| 77.91% | |
| 78.3189% | |
| 78.7465% | |
| -21,840.2768% | |
| -21,126.7942% | |
| -27,718.5607% | |
| -38,387.699% |